... from any ideas, methods, instructions or products referred to in the content or advertisements. Benign prostatic hyperplasia Progression Dihydrotestosterone 5α–Reductase inhibitors Evidence for the involvement of testicular androgens in the onset and progression of BPH first came from...

.... Benign prostatic hyperplasia α–Adrenergic antagonists 5α–Reductase inhibitors European Urology Review Eur Urol 2000;38:2 19 Accepted after revision: October 27, 1999 Medical Therapy for Benign Prostatic Hyperplasia: A Review of the Literature G.M. Clifford, R.D.T. Farmer Public Health and Primary...

... is a 5α–reductase inhibitor that has been used for the treatment of benign prostatic hyperplasia and male–pattern baldness. At doses used clinically, its major effect is through suppression of type 2 5α–reductase, because it has a much lower affinity for the type 1 isoenzyme. Finasteride suppresses DHT...

...F.M.J. Debruyne; A. Jardin; D. Colloi; L. Resel; W.P.J. Witjes; M.C. Delauche-Cavallier; C. McCarthy; C. Geffriaud-Ricouard Objectives: To assess the additive benefit of combining an α 1 -blocker and a 5α-reductase inhibitor. Methods: This European, randomized, double-blind, multicenter trial...